최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, v.9 no.10, 2003년, pp.1035 - 1037
Biedenbach, D.J. , Jones, R.N.
The accuracy of the published disk diffusion quality control (QC) range for linezolid for Staphylococcus aureus ATCC 25923 has been reported to be problematic, prompting a multicenter study to determine if revision was necessary. Five out of seven laboratories reported values outside the current QC ...
Diekema DJ, Jones RN. Oxazolidinone Antibiotics. Lancet 3581975-82.
Microbial Drug Resist Aarestrup 4 137 1998 10.1089/mdr.1998.4.137 Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin
Clin Infect Dis Chow 24 90 1997 10.1093/clinids/24.1.90 Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia
Lancet Gonzales 357 1179 2001 10.1016/S0140-6736(00)04376-2 Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Diagn Microbiol Infect Dis Jones 42 137 2002 10.1016/S0732-8893(01)00333-9 Linezolid resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: Report from the SENTRY Antimicrobial Surveillance Program
Lancet Tsiodras 358 207 2001 10.1016/S0140-6736(01)05410-1 Linezolid resistance in a clinical isolate of Staphylococcus aureus
Zurenko 1999 Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Abstract 848, p.118 Development of linezolid-resistant Enterococcus faecium in two compassionate use program patients treated with linezolid
Stevens TM, Schreckenberger PC, Ristow KL, Eng-Wong LP, Johnson JL, Bouchillon SK. Problems with linezolid and Staphylococcus aureus ATCC 25923 disk diffusion quality control range. In: Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. Abstract 167, p. 151. Washington, DC: American Society for Microbiology.
National Committee for Clinical Laboratory Standards. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline M23-A2. Wayne, PA: NCCLS.
National Committee for Clinical Laboratory Standards. Performance standard for antimicrobial susceptibility testing. Document M100-S12. Wayne, PA: NCCLS.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 공개 리포지터리에 출판본, post-print, 또는 pre-print를 셀프 아카이빙 하여 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.